Table 1.

Long-term tumor-specific protection in cured mice

Tumor4T1CT26
Tumor+ mice70
Mice challenged77

NOTE: Mice cured of CT26 tumors by SM16 pretreatment followed by radiotherapy were rechallenged on opposing flanks with 4T1 and CT26 cells. Mice were followed for development of palpable tumors at the injection site. Table shows the number of mice developing palpable tumors (Tumor+) as compared with the number of mice challenged.